annual CAPEX:
$974.00M+$197.00M(+25.35%)Summary
- As of today (April 18, 2025), ABBV annual capital expenditures is $974.00 million, with the most recent change of +$197.00 million (+25.35%) on December 1, 2024.
- During the last 3 years, ABBV annual CAPEX has risen by +$187.00 million (+23.76%).
- ABBV annual CAPEX is now at all-time high.
Performance
ABBV CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$291.00M+$42.00M(+16.87%)Summary
- As of today (April 18, 2025), ABBV quarterly capital expenditures is $291.00 million, with the most recent change of +$42.00 million (+16.87%) on December 1, 2024.
- Over the past year, ABBV quarterly CAPEX has stayed the same.
- ABBV quarterly CAPEX is now at all-time high.
Performance
ABBV quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$974.00M+$86.00M(+9.68%)Summary
- As of today (April 18, 2025), ABBV TTM capital expenditures is $974.00 million, with the most recent change of +$86.00 million (+9.68%) on December 1, 2024.
- Over the past year, ABBV TTM CAPEX has stayed the same.
- ABBV TTM CAPEX is now at all-time high.
Performance
ABBV TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABBV CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.4% | 0.0% | 0.0% |
| 3 y3 years | +23.8% | +103.5% | +37.4% |
| 5 y5 years | +76.5% | +78.5% | +22.1% |
ABBV CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.1% | at high | +103.5% | at high | +45.6% |
| 5 y | 5-year | at high | +76.5% | at high | +132.8% | at high | +70.9% |
| alltime | all time | at high | +211.6% | at high | +1716.7% | at high | +905.7% |
AbbVie CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $974.00M(+25.4%) | $291.00M(+16.9%) | $974.00M(+9.7%) |
| Sep 2024 | - | $249.00M(+3.3%) | $888.00M(+3.5%) |
| Jun 2024 | - | $241.00M(+24.9%) | $858.00M(+7.9%) |
| Mar 2024 | - | $193.00M(-5.9%) | $795.00M(+2.3%) |
| Dec 2023 | $777.00M(+11.8%) | $205.00M(-6.4%) | $777.00M(-1.0%) |
| Sep 2023 | - | $219.00M(+23.0%) | $785.00M(+5.7%) |
| Jun 2023 | - | $178.00M(+1.7%) | $743.00M(+4.9%) |
| Mar 2023 | - | $175.00M(-17.8%) | $708.00M(+1.9%) |
| Dec 2022 | $695.00M(-11.7%) | $213.00M(+20.3%) | $695.00M(+3.9%) |
| Sep 2022 | - | $177.00M(+23.8%) | $669.00M(-5.6%) |
| Jun 2022 | - | $143.00M(-11.7%) | $709.00M(-6.8%) |
| Mar 2022 | - | $162.00M(-13.4%) | $761.00M(-3.3%) |
| Dec 2021 | $787.00M(-1.4%) | $187.00M(-13.8%) | $787.00M(-10.5%) |
| Sep 2021 | - | $217.00M(+11.3%) | $879.00M(0.0%) |
| Jun 2021 | - | $195.00M(+3.7%) | $879.00M(+2.1%) |
| Mar 2021 | - | $188.00M(-32.6%) | $861.00M(+7.9%) |
| Dec 2020 | $798.00M(+44.6%) | $279.00M(+28.6%) | $798.00M(+17.0%) |
| Sep 2020 | - | $217.00M(+22.6%) | $682.00M(+10.2%) |
| Jun 2020 | - | $177.00M(+41.6%) | $619.00M(+8.6%) |
| Mar 2020 | - | $125.00M(-23.3%) | $570.00M(+3.3%) |
| Dec 2019 | $552.00M(-13.5%) | $163.00M(+5.8%) | $552.00M(+7.8%) |
| Sep 2019 | - | $154.00M(+20.3%) | $512.00M(-20.0%) |
| Jun 2019 | - | $128.00M(+19.6%) | $640.00M(+2.2%) |
| Mar 2019 | - | $107.00M(-13.0%) | $626.00M(-1.9%) |
| Dec 2018 | $638.00M(+20.6%) | $123.00M(-56.4%) | $638.00M(-8.5%) |
| Sep 2018 | - | $282.00M(+147.4%) | $697.00M(+28.8%) |
| Jun 2018 | - | $114.00M(-4.2%) | $541.00M(-2.2%) |
| Mar 2018 | - | $119.00M(-34.6%) | $553.00M(+4.5%) |
| Dec 2017 | $529.00M | $182.00M(+44.4%) | $529.00M(+14.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $126.00M(0.0%) | $461.00M(+2.9%) |
| Jun 2017 | - | $126.00M(+32.6%) | $448.00M(-1.1%) |
| Mar 2017 | - | $95.00M(-16.7%) | $453.00M(-5.4%) |
| Dec 2016 | $479.00M(-10.0%) | $114.00M(+0.9%) | $479.00M(-6.1%) |
| Sep 2016 | - | $113.00M(-13.7%) | $510.00M(-2.7%) |
| Jun 2016 | - | $131.00M(+8.3%) | $524.00M(+3.1%) |
| Mar 2016 | - | $121.00M(-16.6%) | $508.00M(-4.5%) |
| Dec 2015 | $532.00M(-13.1%) | $145.00M(+14.2%) | $532.00M(-1.5%) |
| Sep 2015 | - | $127.00M(+10.4%) | $540.00M(-8.9%) |
| Jun 2015 | - | $115.00M(-20.7%) | $593.00M(-4.4%) |
| Mar 2015 | - | $145.00M(-5.2%) | $620.00M(+1.3%) |
| Dec 2014 | $612.00M(+24.6%) | $153.00M(-15.0%) | $612.00M(+0.3%) |
| Sep 2014 | - | $180.00M(+26.8%) | $610.00M(+8.3%) |
| Jun 2014 | - | $142.00M(+3.6%) | $563.00M(+4.3%) |
| Mar 2014 | - | $137.00M(-9.3%) | $540.00M(+10.0%) |
| Dec 2013 | $491.00M(+47.4%) | $151.00M(+13.5%) | $491.00M(+12.9%) |
| Sep 2013 | - | $133.00M(+11.8%) | $435.00M(+53.2%) |
| Jun 2013 | - | $119.00M(+35.2%) | $284.00M(+9.7%) |
| Mar 2013 | - | $88.00M(-7.4%) | $259.00M(-22.2%) |
| Dec 2012 | $333.00M(-6.5%) | $95.00M(-627.8%) | $333.00M(-2.9%) |
| Sep 2012 | - | -$18.00M(-119.1%) | $342.89M(-19.1%) |
| Jun 2012 | - | $94.00M(-42.0%) | $424.06M(+0.7%) |
| Mar 2012 | - | $162.00M(+54.4%) | $421.15M(+18.3%) |
| Dec 2011 | $356.00M(-20.5%) | $104.89M(+66.1%) | $356.00M(+41.8%) |
| Sep 2011 | - | $63.17M(-30.7%) | $251.10M(+33.6%) |
| Jun 2011 | - | $91.09M(-5.9%) | $187.94M(+94.1%) |
| Mar 2011 | - | $96.85M | $96.85M |
| Dec 2010 | $448.00M(+43.3%) | - | - |
| Dec 2009 | $312.56M | - | - |
FAQ
- What is AbbVie annual capital expenditures?
- What is the all time high annual CAPEX for AbbVie?
- What is AbbVie annual CAPEX year-on-year change?
- What is AbbVie quarterly capital expenditures?
- What is the all time high quarterly CAPEX for AbbVie?
- What is AbbVie quarterly CAPEX year-on-year change?
- What is AbbVie TTM capital expenditures?
- What is the all time high TTM CAPEX for AbbVie?
- What is AbbVie TTM CAPEX year-on-year change?
What is AbbVie annual capital expenditures?
The current annual CAPEX of ABBV is $974.00M
What is the all time high annual CAPEX for AbbVie?
AbbVie all-time high annual capital expenditures is $974.00M
What is AbbVie annual CAPEX year-on-year change?
Over the past year, ABBV annual capital expenditures has changed by +$197.00M (+25.35%)
What is AbbVie quarterly capital expenditures?
The current quarterly CAPEX of ABBV is $291.00M
What is the all time high quarterly CAPEX for AbbVie?
AbbVie all-time high quarterly capital expenditures is $291.00M
What is AbbVie quarterly CAPEX year-on-year change?
Over the past year, ABBV quarterly capital expenditures has changed by $0.00 (0.00%)
What is AbbVie TTM capital expenditures?
The current TTM CAPEX of ABBV is $974.00M
What is the all time high TTM CAPEX for AbbVie?
AbbVie all-time high TTM capital expenditures is $974.00M
What is AbbVie TTM CAPEX year-on-year change?
Over the past year, ABBV TTM capital expenditures has changed by $0.00 (0.00%)